Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus.
about
Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipientsLymphatic disorders after renal transplantation: new insights for an old complicationSystemic and nonrenal adverse effects occurring in renal transplant patients treated with mTOR inhibitorsDo wound complications or lymphoceles occur more often in solid organ transplant recipients on mTOR inhibitors? A systematic review of randomized controlled trialsCorticosteroid and calcineurin inhibitor sparing regimens in kidney transplantationCurrent status of immunosuppression in liver transplantationClinical outcomes in kidney transplant recipients receiving long-term therapy with inhibitors of the mammalian target of rapamycin.Incidence, clinical characteristics and risk factors of late infection in solid organ transplant recipients: data from the RESITRA study group.Sirolimus in pediatric renal transplantation.A comprehensive review of immunosuppression used for liver transplantation.Immunosuppressive cyclosporin A activates AKT in keratinocytes through PTEN suppression: implications in skin carcinogenesis.Relationship between Post-kidney Transplantation Antithymocyte Globulin Therapy and Wound Healing Complications.Peripheral artery disease and chronic kidney disease: clinical synergy to improve outcomes.Tacrolimus does not affect early wound healing in a rodent model of bowel anastomoses and abdominal wall closure.Systematic review of the negative pressure wound therapy in kidney transplant recipients.Effects of perioperative antiinflammatory and immunomodulating therapy on surgical wound healing.Pharmacokinetics, safety, and efficacy of mycophenolate mofetil in combination with sirolimus or ciclosporin in renal transplant patients.Immunosuppression for heart transplantation: where are we now?Mycophenolate mofetil and sirolimus combination in renal transplantation.Wound complications following kidney and liver transplantation.Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients: American College of Chest Physicians evidence-based clinical practice guidelinesEmerging drugs in lung transplantation.Comparison of Minimal Skin Incision Technique in Living Kidney Transplantation and Conventional Kidney TransplantationRisk factors for impaired wound healing in sirolimus-treated renal transplant recipients.Defects in skin gamma delta T cell function contribute to delayed wound repair in rapamycin-treated miceComposite tissue allotransplantation of the face: Decision analysis model.Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients.AGEs Induced Autophagy Impairs Cutaneous Wound Healing via Stimulating Macrophage Polarization to M1 in DiabetesA major burn injury in a liver transplant patient.Surgical wound complications after heart transplantation.Current status of immunosuppressive agents for solid organ transplantation in children.Effects of immunosuppressive therapy on wound healing.Torsion of intraperitoneal kidney transplant.An evaluation of sirolimus in renal transplantation.A drug safety evaluation of everolimus in kidney transplantation.Adverse events associated with mTOR inhibitors.Right diaphragmatic hernia after liver transplant in pediatrics: a case report and review of the literature.mTOR inhibitors in pediatric kidney transplantation.Impact of mTOR-I on fertility and pregnancy: state of the art and review of the literature.Impaired lower extremity wound healing secondary to sirolimus after kidney transplantation.
P2860
Q24246340-E3ED2D1B-8724-4940-A323-49E81C74F5EAQ26785848-6085D39A-E4E5-49BD-8E1F-43BB7D213CECQ26823023-19070C50-B1B4-43F8-A052-D429E9135B77Q26823281-88D9C66F-6C78-4327-A7FF-AF01B67C4FABQ26992343-08E01BBD-9F81-4A36-883F-66FD0DF43E45Q27694591-186F6DA8-CACF-4A8F-AC77-23FDC3DECB22Q30419381-94D97641-42DC-47F8-8300-9C02535E4AB7Q31107136-46E19953-388C-4036-B6F0-A9B488E9312AQ33397668-1D01DF8C-9F39-4628-8597-05CE54CED37EQ33602527-B12BAB36-7CEE-41C6-91F4-E53090D43DA3Q33799731-F108118B-3E25-47A8-9201-3D6605A2217AQ33871855-3CF3EEDA-04A5-40A2-B26E-EFB7947448BAQ34625055-0FCCE7FE-1707-4F5C-B4F8-9A2BE6AAD65CQ35006318-39E24930-471D-4B7B-846A-F49A58F18428Q36241659-34BF8332-2D16-44B7-ABA2-C2C8FEFB10C5Q36289418-E55E05DD-FF9C-4C54-B762-1D1367487D25Q36379888-ED56ADBF-510E-40BB-8FBC-43DFC69598CAQ36433573-B1F779B4-98C9-4AA6-BB99-2815209C1EDDQ36575992-F4DA6171-05B3-4B58-BB52-83EC2E52D49EQ36652072-9FC7BBF1-6F87-4D2A-9B27-50BE404C1AC4Q36724093-B982DDC3-6CD6-4DE8-905D-FE821D2401C5Q36758582-C8124DD6-C839-4E5B-8DB4-02B72AA219E6Q36797796-BDE73423-3013-4363-973D-9584EB42411BQ36889289-1EF14AC3-ECF0-4387-89D6-13F3E651A5CAQ36899362-DF021B7C-FEDF-4487-9FA8-53499D5E95E7Q37204903-74FF47BC-5B24-4285-BB46-7E1AB35BE6E9Q37355472-5DF266C2-8509-4567-AE7B-B346A6A8100DQ37386368-FD718EFF-0DF1-43AC-A155-1F1699230CD9Q37606449-16CC2A33-8685-42C4-8703-04E8BE4BCF3FQ37854845-D2B33938-E5AA-4FC2-AC2C-0742AA6C8B91Q37987565-8805A29C-ED8B-4D70-A931-126F061EEDC6Q37987997-249DDFED-BB22-4904-B265-C38878D23F6DQ38003006-DC65FE70-4CAC-46B0-8B1F-E290152D3C03Q38038696-E462D457-0BEC-4AF8-A64C-E92B0ABA8AEFQ38041260-3D08486A-FF1C-40CD-92CD-D447C5D264AFQ38068519-EC123DD4-3A55-45C6-B73B-468048544DC3Q38084745-FBC3ADB3-A1DE-45DD-B731-1696100341B7Q38112331-1DD18581-D5F7-4150-B905-3414C9E495F2Q38131036-E18A28A5-CBEB-4E6C-A56B-B5AEE775A5E3Q38187974-B23AADC3-666F-4172-9EA8-10865484C47C
P2860
Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Wound-healing complications af ...... n of sirolimus and tacrolimus.
@en
Wound-healing complications af ...... n of sirolimus and tacrolimus.
@nl
type
label
Wound-healing complications af ...... n of sirolimus and tacrolimus.
@en
Wound-healing complications af ...... n of sirolimus and tacrolimus.
@nl
prefLabel
Wound-healing complications af ...... n of sirolimus and tacrolimus.
@en
Wound-healing complications af ...... n of sirolimus and tacrolimus.
@nl
P2093
P1433
P1476
Wound-healing complications af ...... n of sirolimus and tacrolimus.
@en
P2093
Mark D Stegall
Michael B Ishitani
Mikel Prieto
Patrick G Dean
Scott L Nyberg
Timothy S Larson
Walter K Kremers
William J Lund
P304
P356
10.1097/01.TP.0000123082.31092.53
P577
2004-05-01T00:00:00Z